GLYBURIDE; METFORMIN HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for glyburide; metformin hydrochloride and what is the scope of freedom to operate?
Glyburide; metformin hydrochloride
is the generic ingredient in two branded drugs marketed by Bristol Myers Squibb, Actavis Elizabeth, Aurobindo Pharma, Heritage, Impax Labs Inc, Teva, and Zydus Pharms, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.Twelve suppliers are listed for this compound.
Summary for GLYBURIDE; METFORMIN HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 7 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 25 |
Patent Applications: | 74 |
DailyMed Link: | GLYBURIDE; METFORMIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for GLYBURIDE; METFORMIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Texas Health Science Center, Houston | Phase 4 |
Texas Tech University Health Sciences Center | Phase 3 |
University of Illinois at Chicago | Phase 3 |
Pharmacology for GLYBURIDE; METFORMIN HYDROCHLORIDE
Drug Class | Biguanide Sulfonylurea |
Anatomical Therapeutic Chemical (ATC) Classes for GLYBURIDE; METFORMIN HYDROCHLORIDE
US Patents and Regulatory Information for GLYBURIDE; METFORMIN HYDROCHLORIDE
Expired US Patents for GLYBURIDE; METFORMIN HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | GLUCOVANCE | glyburide; metformin hydrochloride | TABLET;ORAL | 021178-001 | Jul 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | GLUCOVANCE | glyburide; metformin hydrochloride | TABLET;ORAL | 021178-003 | Jul 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | GLUCOVANCE | glyburide; metformin hydrochloride | TABLET;ORAL | 021178-002 | Jul 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.